CHMP position statement on Creutzfeldt-Jakob disease and plasma ...
CHMP position statement on Creutzfeldt-Jakob disease and plasma ...
CHMP position statement on Creutzfeldt-Jakob disease and plasma ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
26. Wadsworth JD, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, Collinge J. Tissue<br />
distributi<strong>on</strong> of protease resistant pri<strong>on</strong> protein in variant <strong>Creutzfeldt</strong>-<strong>Jakob</strong> <strong>disease</strong> using a highly<br />
sensitive immunoblotting assay. Lancet 2001;358:171-180.<br />
27. Head MW, Ritchie D, Smith N, McLoughlin V, Nail<strong>on</strong> W, Samad S, Mass<strong>on</strong> S, Bishop M, McCardle<br />
L, Ir<strong>on</strong>side JW. Peripheral tissue involvement in sporadic, iatrogenic, <strong>and</strong> variant <strong>Creutzfeldt</strong>-<br />
<strong>Jakob</strong> <strong>disease</strong>: an immunohistochemical, quantitative, <strong>and</strong> biochemical study. Am J Pathol. 2004<br />
Jan;164(1):143-53.. American Journal of Pathology 2004;164:143-153.<br />
28. Glatzel M, Abela E, Maissen M, Aguzzi A. Extraneural pathologic pri<strong>on</strong> protein in sporadic<br />
<strong>Creutzfeldt</strong>-<strong>Jakob</strong> <strong>disease</strong>. New Engl<strong>and</strong> Journal of Medicine 2003;349:1812-1820.<br />
29. Bruce ME, McC<strong>on</strong>nell I, Will RG, Ir<strong>on</strong>side JW. Detecti<strong>on</strong> of variant <strong>Creutzfeldt</strong>-<strong>Jakob</strong> <strong>disease</strong><br />
infectivity in extraneural tissues. Lancet 2001;358:208-209.<br />
30. Peden AH, Ritchie DL, Head MW, Ir<strong>on</strong>side JW. Detecti<strong>on</strong> <strong>and</strong> localizati<strong>on</strong> of PrPSc in the skeletal<br />
muscle of patients with variant, iatrogenic, <strong>and</strong> sporadic forms of <strong>Creutzfeldt</strong>-<strong>Jakob</strong> <strong>disease</strong>. Am<br />
J Pathol. 2006; 168: 927-935.<br />
31. Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN. The distributi<strong>on</strong> of<br />
infectivity in blood comp<strong>on</strong>ents <strong>and</strong> <strong>plasma</strong> derivatives in experimental models of transmissible<br />
sp<strong>on</strong>giform encephalopathy. Transfusi<strong>on</strong> 1998;38:810-816.<br />
32. Brown P, Cervenáková L, McShane LM, Barber P, Rubenstein R, Drohan WN. Further studies of<br />
blood infectivity in an experimental model of transmissible sp<strong>on</strong>giform encephalopathy, with an<br />
explanati<strong>on</strong> of why blood comp<strong>on</strong>ents do not transmit <strong>Creutzfeldt</strong>-<strong>Jakob</strong> <strong>disease</strong> in humans.<br />
Transfusi<strong>on</strong> 1999;39:1169-1178.<br />
33. Taylor DM, Fernie K, Reichl HE, Somerville RA. Infectivity in the blood of mice with a BSEderived<br />
agent. Journal of Hospital Infecti<strong>on</strong> 2000;46:78.<br />
34. Cervenakova L, Yakovleva O, McKenzie C, Kolchinsky S, McShane L, Drohan WN, Brown P.<br />
Similar levels of infectivity in the blood of mice infected with human-derived vCJD <strong>and</strong> GSS<br />
strains of transmissible sp<strong>on</strong>giform encephalopathy. Transfusi<strong>on</strong> 2003;43:1687-1694.<br />
35. Gregori L, McCombie N, Palmer D, Birch P, Sowemimo-Coker SO, Giulivi A, Rohwer RG.<br />
Effectiveness of leucoreducti<strong>on</strong> for the removal of infectivity of transmissible sp<strong>on</strong>giform<br />
encephalopathies from blood. Lancet 2004; 364: 529-31.<br />
36. Gregori L, Lambert BC, Gurgel PV, Gheorghiu L, Edwards<strong>on</strong> P, Lathrop JT, MacAuley C, Carb<strong>on</strong>ell<br />
RG, Burt<strong>on</strong> SJ, Hamm<strong>on</strong>d D, Rohwer RG. Reducti<strong>on</strong> of transmissible sp<strong>on</strong>giform encephalopathy<br />
infectivity from human red blood cells with pri<strong>on</strong> affinity lig<strong>and</strong>s. Tranfusi<strong>on</strong> 2006; 46: 1152-<br />
1161.<br />
37. B<strong>on</strong>s N, Lehmann S, Mestre-Francès N, Dorm<strong>on</strong>t D, Brown P. Brain <strong>and</strong> buffy coat transmissi<strong>on</strong><br />
of bovine sp<strong>on</strong>giform encephalopathy to the primate Microcebus murinus. Transfusi<strong>on</strong><br />
2002;42:513-516.<br />
38. Herzog C, Salès N, Etchegaray N, Charb<strong>on</strong>nier A, Freire S, Dorm<strong>on</strong>t D, Deslys J-P, Lasmézas CI.<br />
Tissue distributi<strong>on</strong> of bovine sp<strong>on</strong>giform encephalopathy agent in primates after intravenous or<br />
oral infecti<strong>on</strong>. Lancet 2004;363:422-28.<br />
39. Lasmézas CI, Fournier J-G, Nouvel V, Boe H, Marcé D, Lamoury F, Kopp N, Hauw J-J, Ir<strong>on</strong>side J,<br />
Bruce M, Dorm<strong>on</strong>t D, Deslys J-P. Adaptati<strong>on</strong> of the bovine sp<strong>on</strong>giform encephalopathy agent to<br />
primates <strong>and</strong> comparis<strong>on</strong> with <strong>Creutzfeldt</strong>-<strong>Jakob</strong> <strong>disease</strong>: Implicati<strong>on</strong>s for human health. Proc.<br />
Natl. Acad. Sci. 2001;98:4142-4147.<br />
40. Transmissible Sp<strong>on</strong>giform Encephalopathy Advisory Committee June 12th 2009.<br />
www.fda.gov/TransmissibleSp<strong>on</strong>giformEncephalopathyAdvisory Committee.<br />
41. Comoy, E, Dur<strong>and</strong>, V, Lescoutra, N, Freire, S, Correia, E, Ruchoux, MM, Brown, P, Lasmezas, C,<br />
Deslys, JP. 2008 Abstract 0C3.12 PRION 2008, Madrid,8-10th October 2008.<br />
23/26
Change language